hrp0086lbp13 | (1) | ESPE2016

Hyperprolactinemia in Children and Adolescents: A Review of Patients Presenting to a Tertiary Center in Australia

Vora Komal , Ambler Geoffrey , Maguire Ann

Background: Hyperprolactinemia can be physiological or due to a pharmacological/pathological cause. It is relatively rare in childhood and poorly described in the literature.Objective and hypotheses: The aim of this study was to retrospectively evaluate the etiology, clinical findings and management of hyperprolactinemia in children.Method: We reviewed the records of 91 children with hyperprolactinemia (Prolactin level >760 mU/...

hrp0097p1-518 | Growth and Syndromes | ESPE2023

Outcomes of growth hormone treatment in children with Prader Willi Syndrome over a 30-year period at the Children’s Hospital at Westmead, New South Wales Australia

Gamage Dilhara , Chan Albert , Maguire Ann , Srinivasan Shubha , Ambler Geoffrey , Hi Cho Yoon

Background: Prader-Willi syndrome (PWS) is a rare genetic obesity syndrome associated with relative growth hormone deficiency. Scoliosis is a known association of both PWS and growth hormone therapy (GH), although its role in causation remains uncertain. In the literature, short-term and long-term data revealed no adverse effects of GH on scoliosis. As the metabolic and clinical benefit of growth hormone therapy is established in the management of PWS, it is d...